Challenges in the assessment of OTS

According to the latest guideline on OTS1 and a systematic review on the hormonal aspects of OTS,10 despite multiple studies and theories, the exact mechanisms underlying the complex pathophysiology of OTS remain unclear. Theories involving the autonomic, inflammatory, antioxidative, energy-balance, immune and hormonal systems have clarified some aspects of OTS, but could not explain the complete pathophysiology,1 or identify accurate markers of OTS. Proposed markers, including increased plasma glutamine, maximum lactate levels and altered CK reaction to unusual exercise, have been reported in subjects with OTS and related conditions1 2 7 8 15 18 25 26; however, these showed low accuracy for differentiation of healthy and affected athletes, and were not confirmed by further studies. Conversely, impaired hormonal responses to stress induced by maximal exercise have been demonstrated in athletes with OTS,1 10 12–14 and could be precisely distinguished from responses in healthy athletes. However, the reduced hormonal responses to exercise-induced stress verified in these studies could have resulted from impaired signalling from the neuromuscular and cardiovascular systems to the hypothalamus and pituitary, or differences in performance during the stimulation tests.10 12–14 No studies have identified hormonal changes in OTS as the primary dysfunction. Therefore, efforts to identify tools to improve the diagnosis of OTS have been largely unsuccessful,1 2 7–18 25 26 likely owing to challenges in the methodology design of studies on OTS. The most important challenges include: (i) the selection process; (ii) correct diagnosis of OTS; (iii) the study population and sport(s) modalities performed; (iv) proper exclusion of confounding factors; (v) characteristics of the control group(s), with the use of a second control group of non-athletes; (vi) tests and procedures to be performed and (vii) the use of natural-occurring actual OTS, not induced OTS, which tends to manifest as over-reaching.

The improvement of the methodological design in the EROS study21–24 to address these challenges, including the simultaneous analysis of multiple aspects, including basal and stimulated hormones, biochemical data and clinical aspects, concurrent comparisons with non-athletes and a relatively large number of athletes, probably the largest number of participants among studies in OTS,1 10 which strengthen our data, resulted in the observation of unexpected similarities between athletes with OTS and NPAC and differences between these groups and healthy athletes. These observations, along with the scenarios, which were only feasible because of the context of the findings in OTS, and the other behaviours shown by the evaluated parameters, allowed us to propose new risk factors, to predict the occurrence of OTS and to hypothesise a new explanation for OTS, and to understand the adaptive physiological responses of healthy athletes better.

Clinical, metabolic and biochemical behaviors in OTS

In the present analysis, our objective was to understand the context of the five patterns of behaviours observed in the primary findings, and gain new insights on the development and diagnosis of OTS. Most of the non-similar markers between OTS, ATL and NPAC (32/44; 72.7%) reflected losses of conditioning or adaptive processes that athletes typically undergo, or ‘deconditioning’. The most remarkable markers of ‘deconditioning’ identified were21–24: (i) blunted and late GH, cortisol and prolactin responses to an exercise-independent central stimulation test, which may explain the loss of pace and performance during OTS; (ii) reduced testosterone levels, which may explain the loss of muscle mass in athletes with OTS; (iii) increased oestradiol levels without a concurrent increase in testosterone (reduced testosterone-to-oestradiol ratio), which could cause some of the psychological and body metabolism and composition patterns found in OTS; (iv) worse mood states (particularly fatigue, vigour, depression and confusion), likely correlated with worse sleep quality and hormonal dysfunctions and (v) changes in body metabolism and composition (lower metabolic rate and fat burning, more body fat, less muscle mass and less hydration), likely due to a hormonal environment that leads to a muscle-specific catabolic state, and reduction of overall metabolism.

Two specific markers (ie, CK and total catecholamines) indicated an exacerbation of adaptive changes observed in athletes. CK might have resulted from impaired and prolonged muscle recovery, and total catecholamines might have resulted from an attempt to maintain function despite energy depletion. Stimulation of catecholamines might be the shortest and fastest efferent pathway to stimulate the recruitment and availability of energy in an energy-deprived environment, through optimisation of lipolysis, proteolysis and gluconeogenesis in the absence of glycogen and glucose storage.

Seven markers were observed exclusively in OTS (15.9% of non-similar parameters), including ACTH response patterns to stimulation, libido, oestradiol and norepinephrine. These markers can be considered specific markers of OTS, without the need for any adaptations to the standard normal range. Conversely, 38.8% of the selected parameters (26 out of 67 markers) were unaffected by OTS, compared with those typical of athletes or both the athletes and non-athletes, and these parameters most likely have no role in the pathophysiology of OTS.

In short, the finding that approximately two-thirds of the markers underwent physiological adaptations to exercise, the prevailing behaviour observed in OTS were the multiple decrements in athletes’ performance in response to these adaptive changes, which were found in a broad range of parameters, including basal and stimulated hormones, psychological patterns, and body metabolism and composition. The second most observed behaviour was the lack of alterations, while few were present or exacerbated only in OTS.

A new hypothesis for the pathophysiology of OTS

A new hypothesis for OTS

All the data obtained from the EROS study reinforce that adaptive changes occurring in athletes (compared with sedentary participants), are at least partially lost during OTS, as a sort of ‘mix of deconditioning processes’,21–24 wherein the results were similar to those of sedentary participants than to those of healthy athletes. Athletes with OTS do not present absolute altered parameters, but show relative dysfunctional responses compared with healthy athletes. The hormonal and metabolic conditioning processes that athletes undergo could explain the progressive improvement of physical performance, while the losses of these conditioning processes that we observed in OTS could be the cause of the paradoxical loss of performance, which is the hallmark of OTS, and not previously understood.

Furthermore, exacerbated ‘deconditioning’ processes and exclusive findings in OTS could explain the harmful psychological and physical effects observed in individuals with OTS, who lost the benefits of exercising and tended to develop overt and severe issues, particularly in the psychological aspects.

These insights show that we should not usually expect overt biochemical alterations in athletes suspected for OTS, as parameters are usually within the normal range. However, we need to elucidate the particular ranges of each parameter that are to be expected in athletes, as these adapted ranges should be used to analyse athletes at high risk or suspected for OTS. Although we proposed some specific and adapted ranges for the population of athletes, those may be helpful to predict athletes that would further develop OTS, more studies are needed to confirm the consistency of these ranges.

When the results of the EROS study were analysed,21–24 we found that none of the markers evaluated in the EROS study could individually trigger or explain the occurrence of OTS, since none were present in all affected athletes. Each affected athlete showed a unique combination of factors that caused OTS. Thus, OTS likely results from different synergistic combinations and interactions of negative factors, which are unique to each athlete, rather than specific triggers or a single combination of factors for all athletes. Hence, aside from the methodological challenges to research on OTS, the absence of clear findings, inconsistent results between healthy athletes and the general population, and the wide range of individual combinations of triggers, risk factors and patterns of OTS could explain the previous inconclusive findings and unsuccessful attempts to elucidate the mechanisms of OTS.

The combination of altered parameters in OTS, unique to each affected athlete, and the absence of a ubiquitously present alteration allow us to predict that there should not be one single precise marker for OTS. Instead, combinations of those markers that better distinct OTS-affected from healthy athletes should be the most reliable type of assessment of OTS.

Also, the present analysis of the findings of the EROS study allowed us to hypothesise that athletes affected by OTS experience a ‘hyporesponsive’ and ‘hypometabolic’ state, based on the findings of decreased basal metabolic rate and fat burning,23 paradoxical adipocyte saving in fat storages,23 impaired hormonal responses to demands,21 22 and decreased testosterone, testosterone-to-oestradiol ratio and GH, and increased catecholamines.22 24 These findings suggest an antianabolic and procatabolic environment, a global reduction in metabolic pathways and responses, possibly to maximise energy saving and prevent unnecessary energy expenditure, avoid the use of energy storage, and redirect energy for essential pathways, as a major protective mechanism against long-term starvation-like circumstances. Thus, indirect markers of altered metabolism, such as abnormal body fat gain, paradoxical muscle loss and worse libido or mood states (resulted from reduced testosterone), may be early indicators of imminent OTS, even prior to altered biochemical results or decreased performance.

A total of 5 of the 50 excluded parameters were unsuitable for the present analysis because they were predictors that directly depended on participants’ habits, but were not influenced by their physical activity or the presence of OTS. These included eating patterns and concurrent cognitive effort. Among these parameters, we identified the following risk factors or predictors of OTS23 : (i) mean number of daily hours of work/study >8 hours/day; (ii) carbohydrate intake <5.0 g/kg/day; (iii) protein intake <1.6 g/kg/day and (iv) total daily calorie intake <35 kcal/kg/day.23 Fat intake (g/kg/day) did not predict OTS.23 This reinforces the theory that OTS rises from unique combinations of risk factors and stressors, rather than excessive training alone.

In summary, OTS was demonstrated to be a clinical state, which is induced by a distinctive combination of chronic stressors, leading to several synergistic combinations of metabolic, hormonal, inflammatory, immunological, neurological, cardiovascular and psychological dysfunctions that cause a dysfunctional ‘hypometabolic’ and ‘hyporesponsive’ state. The blunted responses to demands are due to multiple failures to achieve the beneficial effects of conditioning that athletes typically experience.

Together, the new findings on OTS allowed us to propose that a comprehensive analysis of the athlete, including the evaluation for risk factors, early clinical signs, and relatively altered biochemistry and hormones, should be the most effective approach for the prevention of imminent OTS, prior to the occurrence of decreased performance.

The triggers, risk factors, proposed pathophysiology and consequences of OTS, and the novel hypotheses derived from the novel markers identified in the EROS study are shown in figure 4. A predictive model with practical applications for the prevention and early detection of OTS, built from the insights of the EROS study, is disclosed in figure 5.

• Download figure
• Open in new tab
• Download powerpoint

Figure 4

Triggers, pathophysiology and consequences of overtraining syndrome (OTS).

• Download figure
• Open in new tab
• Download powerpoint

Figure 5

Predictive model for the identification of overtraining syndrome (OTS). EROS, Endocrine and Metabolic Responses on Overtraining Syndrome; GH, growth hormone; y/o, years old.

However, larger studies are required to confirm our hypothesis. We could not make firm conclusions regarding the physiopathology and clinical and biochemical behaviours in OTS based on our data, but could propose a plausible hypothesis to accurately explain OTS. Studies published after our primary findings reinforce our hypothesis.27–29 Our data could form the basis of further studies in larger groups to confirm our hypothesis.

‘Paradoxical deconditioning syndrome’: renaming ‘overtraining syndrome’

The term ‘overtraining syndrome’ was coined because of the initial idea that excessive training caused the clinical features of OTS. However, our data showed that underperformance (loss of physical performance), the hallmark of OTS, is due to an extensive number of deconditioning processes, caused by unique combinations of clinical and social risk factors.

Our data suggest that OTS is not a simple consequence of ‘overtraining’, but resulted from a combination of different risk factors and harmful clinical behaviours, among which some were unprecedentedly recognised, including insufficient caloric, protein or carbohydrate intake, bad sleep quality and excessive concurrent cognitive effort. The most remarkable aspect of OTS is, therefore, not ‘overtraining’, but a blend of conditioning shortfalls, or ‘unexpected and paradoxical deconditioning’. The loss of multiple conditioning processes naturally leads to a loss in the physical conditioning, clinically observed as reduced performance. On the basis of the evidence shown in the present study, in which the data is likely stronger than previous data, we suggest that the term ‘paradoxical deconditioning syndrome’, is more representative of the key aspects of this syndrome.